OSAIC HOLDINGS, INC. - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$4,698,707
-2.0%
103,521
+21.5%
0.01%
-22.2%
Q2 2023$4,794,872
+24.7%
85,221
+0.2%
0.01%
+28.6%
Q1 2023$3,844,819
+37.2%
85,030
+23.4%
0.01%
+16.7%
Q4 2022$2,802,163
-16.0%
68,915
+35.0%
0.01%
-25.0%
Q3 2022$3,335,000
+6.8%
51,049
+0.2%
0.01%
+14.3%
Q2 2022$3,123,000
+1.8%
50,930
-1.2%
0.01%
+16.7%
Q1 2022$3,068,000
-16.3%
51,560
+7.2%
0.01%
-14.3%
Q4 2021$3,664,000
-22.0%
48,099
+14.6%
0.01%
-30.0%
Q3 2021$4,697,000
-16.8%
41,983
+20.1%
0.01%
-16.7%
Q2 2021$5,645,000
+54.5%
34,963
+16.4%
0.01%
+33.3%
Q1 2021$3,654,000
+35.8%
30,043
+71.0%
0.01%
+28.6%
Q4 2020$2,691,000
+48.7%
17,567
-18.9%
0.01%
+40.0%
Q3 2020$1,810,000
+27.0%
21,670
+11.7%
0.01%0.0%
Q2 2020$1,425,000
+73.6%
19,399
+1.2%
0.01%
+66.7%
Q1 2020$821,00019,1770.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q1 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$31,294,00031.24%
NEA Management Company, LLC 1,590,002$365,593,00010.56%
Ariose Capital Management Ltd 37,900$2,379,0009.30%
ARK Investment Management 9,404,071$590,294,0002.46%
NIA IMPACT ADVISORS, LLC 80,082$5,027,0002.44%
Nikko Asset Management Americas, Inc. 4,619,747$291,044,0002.14%
PLUSTICK MANAGEMENT LLC 50,000$3,139,0001.98%
Integral Health Asset Management, LLC 120,000$7,532,0001.96%
Valiant Capital Management, L.P. 240,683$15,108,0001.73%
Deuterium Capital Management, LLC 18,000$1,130,0001.45%
View complete list of CRISPR THERAPEUTICS AG shareholders